Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence

Schizophr Res. 2019 Jan:203:94-98. doi: 10.1016/j.schres.2018.03.010. Epub 2018 Mar 30.

Abstract

Evidence from randomised controlled trials suggest that both antipsychotic medication and cognitive behaviour therapy (CBT) can be helpful to people with a diagnosis of a schizophrenia spectrum disorder. On this basis, many clinical guidelines recommend that people with psychosis should be offered both antipsychotic medication and CBT and that they should be collaboratively involved in the decisions about which treatment options they choose. The reality of service provision is often very different, with data regarding the availability of such treatment options and the extent of user involvement in decision making suggesting that medication is much more widely available and that service users are often not involved in these decisions, despite retaining decision making capacity. Many patients choose not to take antipsychotic medication, often due to inefficacy or side effects, but there is little evidence regarding whether CBT can be effective as an alternative to antipsychotic medication. However, several recent trials suggest that CBT without medication may be a safe and acceptable option for people with psychosis. The implications for clinical practice and future research are considered and it is recommended that informed choices that include the option to try CBT without antipsychotic medication are supported.

Keywords: Antipsychotics; Clinical trials; Cognitive therapy; Treatment choice.

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use*
  • Cognitive Behavioral Therapy*
  • Combined Modality Therapy
  • Humans
  • Patient Preference*
  • Schizophrenia / drug therapy
  • Schizophrenia / therapy*

Substances

  • Antipsychotic Agents